Solvias in the news

Solvias has earned an EcoVadis Bronze Medal for its progress in environmental, social, and governance initiatives within the life sciences sector.

Umicore PMC is acquiring Solvias' ligand and catalyst technologies to enhance its catalysis services for pharma and fine chemicals by 2026.

Solvias achieved an EcoVadis Bronze Medal for its progress in environmental, social, and governance initiatives within the life sciences sector.

Solvias earned an EcoVadis Bronze Medal for its sustainability performance, reflecting progress in environmental, social, and governance initiatives.

Solvias earned an EcoVadis Bronze Medal, recognizing its strong sustainability performance and commitment to ESG initiatives within the life sciences industry.

Solvias' EcoVadis Bronze Medal recognizes its operational sustainability discipline, which may improve capital efficiency and risk profile amid shifting macroeconomic and commodity cycles.

Solvias' EcoVadis Bronze Medal reflects strong sustainability practices that enhance operational discipline and may reduce costs and investment risk, but its financial benefits depend on economic conditions and effective execution.

Solvias earned the EcoVadis Bronze Medal for advancing sustainability and ESG efforts within its global CMC analytical services business.

Solvias earned the EcoVadis Bronze Medal for significant ESG progress and plans to further enhance sustainability aligned with global standards.

Solvias received the EcoVadis Bronze Medal for its sustainability efforts, ranking among the top 35% of companies assessed worldwide.

Solvias earned an EcoVadis Bronze Medal for its sustainability performance, ranking in the top 35% of companies globally for its ESG initiatives.

Solvias achieved a Bronze Medal from EcoVadis, ranking in top 35% globally for sustainability, showing progress in ESG initiatives and sustainable practices in life sciences analytics.

Solvias, a global CMC analytics provider, earned an EcoVadis Bronze Medal for its sustainability efforts, ranking in the top 35% of companies evaluated globally.

Solvias received an EcoVadis Bronze Medal, ranking in the top 35% for sustainability performance due to its progress in environmental, social, and governance initiatives.

Umicore PMC is acquiring high-throughput screening and ligand technologies from Solvias to enhance its catalyst discovery services, with full transition by 2026.

Solvias identifies five pharma trends at CPHI 2025, focusing on AI analytics, advanced mass spectrometry, CMC development, oral GLP-1 molecules, and patient-centric drug delivery innovations.

Synthetic peptide manufacturing requires centralized, rigorous analytical testing to manage complex synthesis steps and ensure patient safety.

Solvias' Targeted Locus Amplification platform improves the safety of gene therapies by identifying hazardous genetic modifications before patient treatment.

Jarlath Keating joins Solvias as President of U.S. operations to drive growth and innovation in advanced analytical services for biopharma clients.

Solvias' new US center in Research Triangle Park is now cGMP-ready, expanding its analytical testing capabilities for biologics and novel therapies in the US market.